Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hypertension

• JX09 SAD/MAD in Healthy Participants
• A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
• A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients
• A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension
• A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C
• Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension
• Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension
• Efficacy and Safety of Lorundrostat Alone, and in Combination With Dapagliflozin in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria
• A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
• A Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension
• Phase 2, Placebo-Controlled, Study Assessing the Safety and Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Patients With Elevated Eye Pressure
• Polypill for Prevention of Cardiomyopathy
• NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial
• A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
• Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN)
• Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy
• Sodium Lactate Versus Hypertonic Saline Solution in the Treatment of Intracranial Hypertensive Episodes in Severe Brain Injured Patients
• Open-label, Multicenter, multinAtionaL, inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients
• 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
• Forebrain Electroneutral Transporters in Salt-sensitive Hypertension: an MRI Study
• Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
• A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly
• Optimal Blood Pressure Treatment Thresholds Postpartum
• Effect of Treatment of Pre-induction Hypertension on Hemodynamic Stability During Induction of General Anesthesia
• Induced Hypertension in Acute PRogrESsive Perforating Artery Stroke Using Peripheral Dilute noREpinephrine
• Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension
• A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
• Qlaris Phase 2 Study of QLS-111 in POAG and/or OHT Patients
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fasting Conditions in Healthy Volunteers
• A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
• Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project
• Open-Label Extension Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Uncontrolled Hypertension
• Treatment of Elevated Blood Pressures in Early Pregnancy
• The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension
• Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
• Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
• A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
• Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
• Allopurinol Improves Heart Function in African Americans With Resistant Hypertension
• TIPS Plus Cadonilimab in Advanced HCC With Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study
• A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg
• A Prospective, Multicentre, Open-label, Single-arm Interventional Study of Bisoprolol (Nerkardou) (Between Low Dose and High Dose) 5 and 10 mg ODF Treatment In Egyptian Patients With Essential Hypertension
• A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy
• Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
• Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension
• Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery
• A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828
• Anti-CD20 Antibodies for Treatment of SLE-PAH
• Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
• A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Disease
• Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension
• Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism
• Active Screening of Arterial Hypertension by Community Outreach Workers in the Cayenne Metropolitan Area to Reduce the Incidence of Cardiovascular Disease
• Efficacy of L-methylfolate and Methylcobalamine in Treating Hypertension and Its Impact on Serum Homocysteine in Hemodialysis Patients With Resistant Hypertension
• A Phase 2a Study of LAM-001 for the Treatment of PH
• Effect of Sublingually Generated S-nitroso-N-acetylcysteine on Systemic Blood Pressure.
• A Pivotal Study to Evaluate the Efficacy of Lorundrostat (MLS-101) in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen
• Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.
• Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants
• Azilsartan in Patients With Diabetic Kidney Disease and Hypertension
• The Effect Of Nebulizied Nitroglycerin As An Adjuvant Therapy For Persistent Pulmonary Hypertension Of Newborns
• A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2
• Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
• Fractional Flow Reserve to Determine Atherosclerosis Renal Hypertension Stenting
• A Study of Macitentan in Children Below 2 Years of Age
• The Effect of Pituitrin on the Patients With Pulmonary Hypertension Undergoing Cardiac Surgery
• rhBNP in Type 3 Pulmonary Hypertension
• Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)
• Cardiovascular Risk Reduction in Epilepsy
• Contributions to Hypertension With Androgen Deprivation Therapy
• A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery
• Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia
• Intensive Postpartum Antihypertensive Treatment
• "Community-based, eHealth Supported Management of Cardiovascular Risk Factors by Lay Village Health Workers (ComBaCaL aHT TwiC 1 & ComBaCaL aHT TwiC 2)
• Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)
• The Outcomes of Hypertension in Obese Versus Non-obese Pregnant Women
• An Comparative Pharmacokinetic Study of Amlodipine Besylate Controlled-release Tablets,China in Normal, Healthy, Adult, Human Subjects Under Fasting Conditions
• A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets
• A Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
• An Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
• Chymase Angiotensin-(1-12) Axis In Hypertensive Disease
• A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
• Olive Leaf Extracts in the Control of Hypertension
• A Study to Evaluate the Efficacy and Safety of AD-209
• Felodipine Modified-release Tablets and Felodipine Sustained Release Tablets in Healthy Subjects Under Fasting State: Single Dose, Randomized, Open, 2-treatment，2-period，Crossover Comparative Pharmacokinetic Study
• MK-5475-013 INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of MK-5475 (an Inhaled sGC Stimulator) in Adults With PH-COPD
• Study on Human Mass Balance of SPH3127 Tablets
• Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
• Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
• Consistency of Electrical Cardiometry and Pulmonary Artery Catheter
• OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects
• Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes
• Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects
• Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAH
• Study of Early Pharmaceutical Intervention for Cardiovascular Disease Prevention in Stage 1 Hypertension
• A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
• Inhaled iMatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)
• Superselective Adrenal Arterial Embolization for Resistant Hypertension
• Safest Choice of Antihypertensive Regimen for Postpartum Hypertension
• Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension
• Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects
• Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy
• Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy Subjects
• The Efficacy of Qianglidingxuan Tablets in the Treatment of Hypertension
• Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy
• The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot Study
• A Multicenter, Randomized, Double-blind, Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS
• A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension
• Study With CIN-107 Following Multiple Oral Ascending Doses in Healthy Subjects
• A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
• Empagliflozin in Pulmonary Arterial Hypertension
• A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single a
• Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial
• Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage
• Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients
• Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients
• Study to Evaluate the Pharmacokinetics of CIN-107 in Subjects With Varying Degrees of Renal Function
• Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
• Effect of Amlodipine on the Lipid Profile of Newly Diagnosed Hypertensive Patients
• Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124
• A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension
• PET Image in PAH Patients
• A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients
• Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension
• Efficacy and Safety Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension
• A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease
• A Study of Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor Agonist
• Effects and Safety of Clonidine Patch on Young and Middle-aged Smokers With Mild Hypertension
• Insomnia Prevalence and Treatment Impact on Systemic Hypertension
• Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
• Low-dose Quadruple Combination Therapy in Patients With Hypertension
• A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy Volunteers.
• Hypertension in Young Adults Trial
• A Phase 3 Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension
• Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension
• A Phase III Trial to Determine the Efficacy and Safety of Presendin in IIH
• Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH
• A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)
• Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension.
• To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension
• Effect of Different Antihypertensive Drugs on Central Blood Pressure
• A Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled Hypertension
• Endogenous Glucose Production and Acute Sympathetic Blockade
• Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
• Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection
• 24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.
• Olive Leaf Extracts in the Control of Cardiovascular Risk
• Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension.
• A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to th
• Effectiveness and Safety of Combination of Amlodipine and Zofenopril in Hypertensive Patients Versus Each Monotherapy
• Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl
• Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN)
• TreatIng Microalbuminuria Over 24 Weeks in Subjects With or Without Type 2 Diabetes or HYpertension
• Study MIPAE - Melatonin and Essential Arterial Hypertension
• Effectiveness and Safety of Combination of Nebivolol and Zofenopril in Hypertensive patIents Versus Each Monotherapy
• Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects
• PSLT Compared to Prostaglandin Analogue Eye Drops
• Vonoprazan Efficacy to Prevent Post Variceal Band Ligation Ulcer
• Effect of CS1 in Subjects With Pulmonary Arterial Hypertension
• A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers
• Spironolactone in CKD Enabled by Chlorthalidone: PILOT
• a Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients With Renal Insufficiency and Healthy Subjects
• A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension
• Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients
• Effect of PRM-125 on Ambulatory Blood Pressure
• Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension
• Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function
• A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
• Dapagliflozin in Pulmonary Arterial Hypertension
• A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease
• Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension
• Diuretics and Volume Overload in Early CKD
• 24 Hour Ambulatory Cardiac Oxygen Consumption
• Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVD
• A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension
• Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension
• A Study to Test Whether Two Different Doses of BI 685509 Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)
• Occurrence of Dyskalemia With Treatment for Hypertension
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension
• Moxonidine Effects on Neuropeptide Y
• Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans
• Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension (ATENAS)
• Postpartum Hypertension Study
• A Study of CIN-107 in Patients With Uncontrolled Hypertension Receiving 1 Antihypertensive Agent
• Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension
• Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study).
• Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension.
• Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)
• A Clinical Trial to Evaluate Drug-drug Interactions and Safety Between "BR1015-1" and "BR1015-2" in Healthy Volunteers
• Morning Versus Bedtime Dosing of Antihypertensive Medication
• A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52L in Healthy Volunteers
• A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers
• Sacubitril/Valsartan Versus Valsartan for Hypertensive Patients With Acute Myocardial Infarction
• Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension
• Antihypertensive Deprescribing in Long-term Care
• A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult Volunteers
• A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)
• s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension
• A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
• Extension Study of Carvedilol RCT Study
• Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension
• Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Sildenafil
• Effect of BIA 5-1058 400 mg on Warfarin Pharmacokinetics
• Xenon MRI Pulm Hypertension
• Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan
• Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058
• Absorption, Distribution, Metabolism and Excretion of BIA 5-1058
• Effect of Food on BIA 5-1058
• Role of L-citrulline in Prevention of Pregnancy Associated Hypertension
• China Stroke Primary Prevention Trial for Subjects With Hypertension and MTHFR 677 TT Genotype (CSPPT2-TT)
• China Stroke Primary Prevention Trial for Subjects With H-type Hypertension and MTHFR 677 CC/CT Genotype
• Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension
• Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension
• Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe CKD
• A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
• A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants
• Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH
• Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension
• A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF
• To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
• A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1)
• The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability.
• Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.
• Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension
• First-in-Human Study of VB0004 in Healthy Subjects and to Patients With Mild to Moderate Hypertension With Low Cardiovascular Risk
• The COlchicine HypERtENsion Trial
• Apabetalone for Pulmonary Arterial Hypertension
• Endovenous Sildenafil Early Management in Newborns Pulmonary Hypertension
• Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension
• Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension
• Trial of AD113 and Atomoxetine in OSA Patients With Hypertension
• Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution
• Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn
• A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality
• Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD
• A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Covid-19 Patients With aPH
• Microbiota Transplant Therapy for Pulmonary Arterial Hypertension: Early Safety and Feasibility Study
• Telemonitoring to Treat Group 2 Pulmonary Hypertension
• A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
• Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH)
• MR Antagonist and LSD1
• Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
• Effectiveness of the Use of Methyldopa in Comparison to Captopril in Hypertension Post Partum
• Reversing Glucose and Lipid-mediated Vascular Dysfunction
• Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients
• Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension).
• Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
• Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
• Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk PAH Patients
• Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension
• Effect of LCZ696 on Urinary Microalbumin and Pulse Wave Velocity in Perimenopausal Patients With Hypertension
• Single-Dose, Open Label Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)
• Effect of Berberine Hydrochloride on Blood Pressure and Vascular Endothelial Function in Patients With Hypertension
• Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension
• A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community
• Initial Dual Oral Combination Therapy Versus Standard-of-care Initial Oral Monotherapy Prior to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension
• Pulmonary Hypertension SOLAR
• Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device
• Lasix for the Prevention of De Novo Postpartum Hypertension
• Study of LL-BMT1 in Patients With Elevated Intraocular Pressure
• Effect of Eplerenone on Novel Biomarkers of Mineralocorticoid Receptor Activation (ENOVA)
• Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
• Anti Inflammatory Treatment of Hypertension
• Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution)
• A Study of the Efficacy and Safety of MK-5475 in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)
• Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal Hypertension
• SHAPE of Portal Hypertension in Children
• Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents
• A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure
• A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2)
• Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.
• EUS-guided PSE in Combination With EUS-guided Treatment of Varices for Patients With Portal Hypertension
• Treatment of Early Hypertension Among Persons Living With HIV in Haiti
• Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects
• Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension
• Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil
• A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure
• Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers
• To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia
• Hemodynamic Stability of Dexmedetomidine in Hypertensive Patients Undergoing Laparoscopic Cholecystectomy
• Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）
• Sacubitril/Valsartan in Resistant Hypertension
• MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension
• Effect of Calcium- D Supplement on Hypertension
• Furosemide vs. Placebo for Severe Antepartum Hypertension
• THERAPY-HYBRID-BPA Trial
• Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102
• Levosimendan Administration in Pulmonary Hypertension
• PGI2 Versus Nitroglycerine for Management of Pulmonary Hypertension After Valve Surgeries
• Postpartum Hypertension, Tight vs Liberal Control Trial
• Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
• Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension
• FM101 Safety, Tolerability, Efficacy Study in the Patients With Open-Angle Glaucoma or Ocular Hypertension
• A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (STELLAR)
• Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic
• Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)
• MANP in African Americans With Hypertension
• Copd Exacerbation and Pulmonary Hypertension Trial
• Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1)
• Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients
• Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension
• Management of Hypertension Utilizing Trained Community Health Worker in Rural Municipalities of Nepal
• A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
• A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)
• Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
• Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
• The Study of Dachengqi Decoction Combined With Probiotic L92 to Improve the Prognosis of Patients With Severe Abdominal Hypertension
• Study to Assess the Safety, Tolerability, and Pharmacokinetics of REGN5381 (an NPR1 Agonist) in Adult Humans
• Management of Angiotensin Inhibitors During the Perioperative Period
• A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers
• A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension
• Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension
• AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
• Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension
• Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension
• Acute Haemodynamic Study of TPN171H in Patients With Pulmonary Arterial Hypertension
• Neuroinflammation in Hypertension Study
• Interactions of Medicine and Exercise With Meal Timing
• Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension
• S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients.
• GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
• Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension
• A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
• Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging
• Efficacy of Nifedipine Versus Hydralazine in Management of Severe Hypertension in Pregnancy
• BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF
• Sympathetic Regulation of Large Artery Stiffness in Humans With ISH
• Positioning Imatinib for Pulmonary Arterial Hypertension
• Gut Butyrate and Blood Pressure in African Americans
• Spermidine Anti-Hypertension Study
• Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma
• Effect of Gut Microbiome Restoration on Primary Hypertension Via Dietary Intervention
• Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)
• Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma
• Anticoagulation Therapy After Splenectomy in Cirrhosis Patient
• Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension
• VASCULAR AND RENAL IMPACT OF ENDOTHELIN-1 RECEPTOR BLOCKADE IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION
• Heat-sensitive Moxibustion Self-administration in Patients in the Community With Primary Hypertension: Protocol for a Multi-center, Pragmatic, Non-randomized Trial
• The Standardized Management of Hypertension in Rural Shaanxi
• Influence of the Autonomic Nervous System in Response to Exercise in Hypertensive Individuals
• MK-5475 in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006)
• African American Study of Kidney Disease and Hypertension
• CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension
• Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy
• Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.
• Persistent Postpartum Hypertension Pilot Trial
• Postpartum Management of Gestational Hypertensive Disorders Using Furosemide
• Comparison of Spironolactone and Amiloride on Home Blood Pressure in Resistant Hypertension
• Coronavirus (COVID-19) ACEi/ARB Investigation
• Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn
• Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome
• Pharmacokinetics, Safety and Efficacy of BIA 5-1058 in PAH
• Clinical Trial to Evaluate the Efficacy and Safety of CKD-386
• Effect of Atorvastatin on Carotid Intima Media Thickness
• Repurposing Colchicine to Improve Vascular Function in Hypertension
• A Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension
• TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH
• Firibastat in Treatment-resistant Hypertension
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
• A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
• Comparative Effects of Perindopril and Zofenopril on Blood Pressure Control and Oxidative Status Blacks Hypertensive Patients.
• Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period
• Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide
• Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension
• The Effect of Oxygen Therapy on 6MWD in PAH and CTEPH Patients With Hypoxemia
• Short Term Effect of Empagliflozin in Hypertension
• Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855
• A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension
• Effect of Vasopressin vs Norepinephrine on Pulmonary Oxygenation and Lung Mechanics in Patients With Hypertension Therapy During One-lung Ventilation : Preliminary Study
• Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451
• Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine
• Safety and IOP-Lowering Effects of WB007
• A Study to Evaluate the Effect of Latanoprostene Bunod Ophthalmic Solution 0.024% on Episcleral Venous Pressure and Outflow Facility in Participants With Ocular Hypertension
• A Phase III Multinational Multicenter Investigator-Masked Randomised Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Oral CXA-10 in Pulmonary Arterial Hypertension
• Mechanism of Masked Hypertension - Intervention
• Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab (Olmesartan 20 mg/Amlodipine 5 mg/Rosuvastatin 5 or 10 mg) in Hypertension Patients With Low-Intermediate Risk for Cardiovascular Disease
• Nicotinamide Riboside as an Enhancer of Exercise Therapy in Hypertensive Older Adults (The NEET Trial)
• Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
• Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants
• A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH
• A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx
• N-acetyl Cysteine in Post-reperfusion Pulmonary Injury in Chronic Thromboembolic Pulmonary Hypertension.
• Chinese Medicine Treat for Hypertensive Renal Injury
• A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
• Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance
• Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
• Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia
• Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension
• CXA-10 Study in Subjects With Pulmonary Arterial Hypertension
• Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury
• Single Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606
• Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)
• Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension
• Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study
• A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012
• Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study
• To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
• Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome
• The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers
• The Role of Somatostatin in the Hemodynamics of the Hepatic Circulation in Patients Undergoing Liver Resection
• Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension
• Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease
• Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil
• BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination
• Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level
• Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes
• Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension
• Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension
• Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma
• Clinical Efficacy of Telmisartan in Reducing Cardiac Remodeling Among Obese Patients With Hypertension
• Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia
• Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso
• Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients
• Is Blood Flow Through IPAVA and PFO Related to Breath-hold and SCUBA Diving-induced Pulmonary Hypertension?
• A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag
• A Study to Evaluate ALN-AGT01 in Patients With Hypertension
• EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial
• Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity
• Efficacy of Chlorthalidone and Hydrochlorothiazide Combined With Amiloride on Blood Pressure in Primary Hypertension.
• A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension
• Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension
• A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)
• Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.
• Hypertension And Surgery Study: Evaluating the Implementation of a Hypertension Guideline Protocol
• Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors
• Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
• A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension
• Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
• Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
• Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil
• Acute Control of Chronic Hypertension
• Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan
• The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin
• Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6
• Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
• Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan
• Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension
• A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis
• Postpartum NSAIDS and Maternal Hypertension
• A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular Hypertension
• Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
• Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension
• Efficacy and Safety of Leningrado 5 Association in the Treatment of Hypertension
• Efficacy and Safety of Leningrado Association in the Treatment of Hypertension
• Mechanisms of EPO-induced Hypertension
• Dietary Counseling or Potassium Supplement to Increase Potassium Intake in Patients With High Blood Pressure
• A Clinical Study to Find Out if Macitentan is Effective and Safe in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
• Upfront Combination Pulmonary Arterial Hypertension Therapy
• Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting
• Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004
• Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
• Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial Hypertension
• Chlorhexidine Mouthwash and Oral Nitrate in Adults With Pulmonary Hypertension
• HVPG-guided Laparoscopic Versus Endoscopic Therapy for Variceal Rebleeding in Portal Hypertension: A Multicenter Randomized Controlled Trial (CHESS1803)
• Olaparib for PAH: a Multicenter Clinical Trial
• MANP in Hypertension and Metabolic Syndrome
• Trial of Oral Melatonin in Elevated Blood Pressure
• Sildenafil in Hemodialysis Patients With Pulmonary Hypertension
• A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
• Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients
• This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thro
• Salt-Sensitivity and Immunity Cell Activation
• A Randomized Trial of Oral Misoprostol Alone Versus Oral Misoprostol Followed by Oxytocin for Labour Induction
• Clinical Trial to Evaluate Pharmacokinetic Profiles and Safety Between CKD-385 and D935 in Healthy Volunteers
• Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes
• A Study of Single Doses of MK -5475 on Pulmonary Vascular Resistance (MK-5475-002)
• Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
• Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine
• Carvedilol for Prevention of Esophageal Varices Progression
• Angiotensin II in General Anesthesia
• A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects
• CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH
• Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension
• A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx, an Antisense Inhibitor Administered Subcutaneously to Hypertensive Subjects With Controlled Blood Pressure
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058
• DE-117 Spectrum 5 Study
• Fractionated Vs Single Dose Injection for Spinal C-Section in Patients With Pregnancy-Induced Hypertension
• Nighttime Losartan in Continous Ambulatory Peritoneal Dialysis (NVCAPD)
• A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
• A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study
• A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment
• Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients
• A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
• MR Antagonist and STRIATIN
• ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD)
• Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety
• Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers
• Pharmacokinetics and Safety Profile of CKD-333
• Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects
• A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension
• Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study
• Effects of DHEA in Pulmonary Hypertension
• Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension
• Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.
• Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial
• Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking Amlodipine
• Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
• Metformin for Pulmonary Hypertension HFpEF
• A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
• Spironolactone Versus Indapamide in Obese and Hypertensive Patients
• Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial Hypertension
• Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients
• Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension
• A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Healthy Volunteers
• Angiotensin 1-7 in Obesity Hypertension
• The Role of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD
• Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric
• Is Procardia XL 60 mg Q Daily Equivalent to 30 mg XL Given Twice Daily?
• Nighttime Valsartan in Hemodialysis Hypertension
• Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension
• A Study of LY3322207 in Healthy Participants and in Participants With Hypertension (High Blood Pressure)
• Adiposity and Endothelin Receptor Function
• Fixed-Free HTN Trial
• Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia
• Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease
• Magnesium Sulphate Versus Lidocaine for Control of Emergence Hypertension
• Furosemide for Accelerated Recovery of Blood Pressure Postpartum
• Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH
• Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension
• Role of ARNi in Ventricular Remodeling in Hypertensive LVH
• L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia
• Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF
• A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety
• Effects of Silybin in Hypertensive Patients
• Unilateral Laparoscopic Adrenalectomy for Resistant Hypertension in Patients With Adrenal Diseases
• China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension
• Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension
• Subcutaneous Elafin in Healthy Subjects
• An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension
• Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition
• Response to Anti-hypertensives in Pregnant and Postpartum Patients
• The TARGET BP OFF-MED Trial
• Surgical Idiopathic Intracranial Hypertension Treatment Trial
• EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension
• A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
• A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
• A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension
• Effect of BIA 5 1058 on Cardiac Repolarization
• Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients
• High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension
• H-Type Hypertension Precision Medicine Trial
• Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder in Healthy Normal Volunteers
• Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension
• N-of-1 Trials In Children With Hypertension
• Evaluation of Safety and Efficacy of Brimonidine Tartrate Ophthalmic Suspension
• PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)
• Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive Women
• Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Children
• A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.
• A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients
• L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension
• Efficacy of Fixed-doses of Antihypertensive and Statin Drugs
• Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension
• Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil
• Uric Acid Effects on Endothelium and Oxydative Stress
• Laser-1st vs Drops-1st for Glaucoma and Ocular Hypertension
• Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes
• Femoral Peri-arterial Local Anesthetic Injection Decreases Tourniquet Associated Ischemic Hypertension
• Vascular Dysfunction in Hypertensive Postmenopausal Women
• ORal IrON Supplementation With Ferric Maltol in Patients With Pulmonary Hypertension (ORION-PH-1)
• Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension
• (RIGHT HEART III Study - Right Ventricular Hemodynamic Evaluation and Response to Treatment)
• Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in Hypertension
• Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)
• Cardiometabolic Disease and Pulmonary Hypertension
• Spironolactone Therapy in Chronic Stable Right HF Trial
• A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia
• Treating Nocturnal Hypertension and Nocturia in African American Men
• Safety, Tolerability and Preliminary Efficacy of Unilateral Latanoprost-loaded Punctual Plug -EXP-LP
• A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH
• Treatment of Supine Hypertension in Autonomic Failure (CPAP)
• Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension
• Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension
• Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
• ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension
• A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension
• Bedtime ACEIs/ARBs Versus Morning ACEIs/ARBs for Reverting Non-dipping Hypertension
• A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension
• The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension
• Effect of Inhaled Albuterol in Pulmonary Hypertension
• Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension
• Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2)
• Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
• A Clinical Trial to Evaluate Safety and Efficacy of a Renal Denervation System in Treatment of Hypertension
• Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)
• The Tolerability and Pharmacokinetics of Multiple Doses of SPH3127 in Chinese Healthy People
• Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension
• Olaparib for PAH: a Pilot Study
• A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers
• The Effect of Food Intake on the Pharmacokinetic of Single Dose SPH3127 Tablets in Chinese Health Subjects
• Fimasartan in the Senior Subjects
• Goal Oriented Strategy to Preserve Ejection Fraction Trial
• BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension
• Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
• Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan
• the Effect of Tracleer on Tourniquet-associated Hypertension
• Pulmonary Hypertension and Anastrozole Trial
• S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension
• Mechanisms of Refractory Hypertension (Reserpine)
• Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan
• A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study
• Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia
• A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness
• Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy
• Safety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulmonary Arterial Hypertension
• Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy
• Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans
• A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)
• Hemodynamic Changes During Operative Hysteroscopy
• Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia
• Matão Controlling Hypertension (MatCH Study): Rationale and Design
• Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen
• Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma
• Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis
• Single Ascending Dose Study of Safety and Tolerability of SPH3127 Tablet in Chinese Healthy Volunteers
• Manidipine Versus Amlodipine in Patients With Hypertension
• Clinical Trial to Evaluate the Efficacy and Safety of YHP1701
• Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC) in Patients With Stable Type 2 Diabetes and Hypertension
• Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin
• Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.
• Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension
• Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
• Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER
• Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia
• Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily
• Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension
• SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)
• Fixed Combination for Lipid and Blood Pressure Control
• Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertension
• Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF
• Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients
• Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
• Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions
• Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
• Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD
• Hypertension In Postpartum Preeclampsia Study
• Intensive Blood PRessure Control in Patients With Acute Type B AortIc Dissection
• Acute Effect of Agiotensin-(1-7) in Healthy and Hypertensive Subjects
• Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension
• Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)
• Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension
• A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT
• Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
• A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction
• Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives
• Doppler Ultrasound Hepatic Vein Waveform as a Non-invasive Tool in the Assessment of Severity of Portal Hypertension
• Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With Hypertension
• An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension
• Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)
• : Vascular Function in Health and Disease
• Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic Hypotension
• Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension
• Comparison of Blood Pressure Lowering Effect Between Fimasartan and Losartan
• Clinical Trial to Evaluate the Efficacy and Safety of DP-R212
• Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension
• Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Fuzheng Huayu and Entecavir
• Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir
• Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension
• Effect of Sedation on Intra-abdominal Pressure
• Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness
• Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients
• Changes in Central Arterial Pressure When Comparing ACOG Hypertensive Urgency Protocols
• A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)
• A Study to Investigate the Safety and Effect of the Study Drug (FE 204205) in Patients With Cirrhotic Portal Hypertension
• Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients
• Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPS
• Comparison of Topical Analgesic With Saline Rinses in Post Extraction Healing
• A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male Subjects
• A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605
• Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT
• Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension
• TARGET BP I Clinical Trial
• Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis
• A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension
• NSAID Use in Postpartum Hypertensive Women
• Doxazosin and Ramipril in Hypertension
• Randomized Controlled Trial of Renal Denervation for Resistant Hypertension
• [18F]FES PET/CT in PAH
• Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia
• Effect of Antihypertensive Agents on Diastolic Function in Patients With Sleep Apnea
• Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension
• Antihypertensive Treatment in Masked Hypertension for Target Organ Protection
• Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
• The Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of Pregnancy
• Study of CS-3150 in Patients With Essential Hypertension
• Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects
• Crossover Study From Macitentan or Bosentan Over to Ambrisentan
• Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury
• An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension
• Study of Remodulin® in Pediatric Pulmonary Hypertension With Single Ventricular Physiology After Fontan Surgery
• Comparison of Blood Pressure Control Achieved in Antihypertensive or Generic Drugs in Moderate to Severe Hypertensive Patients
• Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension
• Comparison of Optimal Hypertension Regimens
• Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID)
• Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension
• Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension
• Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG
• Targeting Right Ventricle in Pulmonary Hypertension Gilead
• Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)
• Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)
• A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study
• A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study
• Safety Study of RMJH-111b to Treat Essential Hypertension
• Phosphate in Blood Pressure Regulation
• Feasibility Study of the Intensive Systolic Blood Pressure Control
• ToRsemide for pOstpartum HYpertension
• Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B
• Pilot Study of Aprepitant Effect on Aldosterone Secretion in Diabetic Patient (Diabetes Mellitus) With Hypertension Associated With Low Renin
• Study of CS-3150 in Patients With Severe Hypertension
• Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment
• Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria
• Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients
• Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension
• Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A
• Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension
• Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
• A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma
• Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
• A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With Hypertension
• Acute Effects of Benzbromaron on the Pulmonary Circulation
• Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy Volunteers
• Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension
• Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure
• The Precision Hypertension Care Study
• Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy
• Right Ventricular Metabolism in Pulmonary Arterial Hypertension
• A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.
• Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives
• International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan
• Chronic Clinical Effect of Acetazolamide
• Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension
• The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
• Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585
• N-of-1 Trials for Blood Pressure Medications in Adults
• Pharmacodynamic Effects of Riociguat in Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
• A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma
• Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease
• A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension
• Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans
• Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients
• Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
• Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH
• Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic
• Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
• Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension
• Low-dose Combination of Three Antihypertensive Drugs
• Once-daily Fixed Combination of Three Antihypertensive Drugs
• Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide
• Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male Subjects
• Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic
• Canrenone as Add-on in Patients With Essential Hypertension
• A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension
• Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
• A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension
• Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension
• Serelaxin To Lower Portal Pressure
• Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate
• A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
• Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.
• Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
• Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination
• Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension
• Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH
• Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
• Macitentan in Pulmonary Hypertension of Sickle Cell Disease
• Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension
• The Effect of Melatonin on Early Signs of Hypertension in Teenagers With Diabetes Mellitus Type 1
• Thiazide Diuretics for Hypertension in Kidney Transplant Recipients Using Tacrolimus
• Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension
• A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension
• A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension
• An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
• Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
• Riociguat for Sarcoidosis Associated Pulmonary Hypertension
• A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-
• The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT).
• Effects of Sildenafil on Penile Vascular Function in Hypertensive Men With Erectile Dysfunction
• Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment
• Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension
• Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart Rate
• Azilsartan in Chinese Patients With Mild and Moderate Hypertension
• Nesiritide in Hypertension
• Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension
• Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
• Oral Sildenafil and Intravenous Milrinone on Postoperative Pulmonary Hypertension
• Trial to Evaluate the Efficacy and Safety of HCP1302
• ABI-009, an mTOR Inhibitor, for Patients With Severe Pulmonary Arterial Hypertension
• CKD-330 Phase 3 Trial in Amlodipine Non-responder
• Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)
• The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment
• Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension
• Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma
• The Effects of Doxazosin and Nifedipine on Blood Pressure Variability and Uric Acid in Plasma in Hypertensive Patients
• Riociguat in Children With Pulmonary Arterial Hypertension (PAH)
• Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
• The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension
• The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine
• Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation
• Positron Emission Tomography (PET) Study to Evaluate Biodistribution of [11C]-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients
• Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs
• A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice
• Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension
• Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)
• An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert
• The Effect of Pre-discharge Blood Pressure of Patients With Asymptomatic Severe Hypertension in Emergency Department
• Early Vascular Adjustments During Hypertensive Pregnancy
• 28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
• The Effect of Sodium Nitrite on Renal Function and Blood Pressure in Hypertensive Versus Healthy Subjects
• Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled
• Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control
• Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control
• Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension
• Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia
• Oral Nitrite Trial for Hypertension and Metabolic Syndrome
• Safety and Efficacy Study of LHW090 in Resistant Hypertension Patients
• Postoperative Pain and Angiotensin II Receptor Antagonists
• The Effects of Nifedipine and Metoprolol on Blood Pressure Variability in Northern Chinese
• Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes
• Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices
• Surrogate Markers of Portal Pressure
• Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Beta-blockers in Pulmonary Arterial Hypertension
• Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject
• Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
• REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial
• The Effects of Scalp Block With Bupivacaine Versus Levobupivacaine
• PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton
• Fimasartan Achieving SBP Target (FAST) Study
• Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control
• Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension
• Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control
• Iloprost for Bridging to Heart Transplantation in PH
• Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk
• Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension
• Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension
• Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension
• POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma
• To Compare the Efficacy and Safety of Carvedilol With or Without Simvastatin in Patients With Portal Hypertension and Esophageal Varices.
• Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
• A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With Hypertension
• Prevention of Severe Postpartum Hypertension
• RAS Peptide Profiles in Patients With Arterial Hypertension
• A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment
• Evaluation of Periop Biochemical Stress Factors in Craniotomy Neurosurgical Procedure With Respect to Preop Hypertension
• Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide
• Effect of Sildenafil for Sustained PAH After MV Surgery (SUPERIOR Trial)
• The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy
• Corever in the Treatment of Hypertension
• Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH)
• Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension
• Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension
• Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension
• Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients
• Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.
• Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension
• Effects of Metoprolol and Amlodipine on Cardiac Remodeling, Arrhythmias and Blood Pressure Variation in Hypertensive Patients With Sleep Apnea Syndrome
• Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension
• Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)
• Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents
• BRAVE Study With Uncontrolled Essential Hypertension (BRAVE Study)
• Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male Volunteers
• Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects
• Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405
• PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial
• Blood Pressure Regulation - Role of Potassium
• PDEI Following Mitral Valve Surgery in Patients With Pulmonary Hypertension
• Lowering Blood Pressure in Primary Care in Vienna
• Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Patients With Hypertension and Albuminuria
• Preventing Sickle Cell Kidney Disease
• INTERVENCION Trial
• Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
• Optimum Treatment for Drug-Resistant Hypertension
• A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy
• A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy
• CKD-828 (80/5mg) Pharmacokinetic Study
• Dose-Ranging Study of the Bimatoprost Ocular Insert
• Comparative Effects of Moxonidine on Bone Metabolism, Vascular and Cellular Aging in Hypertensive Postmenopausal Women
• Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation
• Comparison of Single and Combination Diuretics in Low-Renin Hypertension
• A Phase 1 Food Effect Study of TAK-536TCH Final Formulation Tablet
• Role of the Nitric Oxide (NO) in Pre-oxygenation Before Anesthetic Induction in Patients With a Pulmonary Hypertension in Cardiac Surgery. Pilot Study of Feasibility
• A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects
• Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis
• A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan
• Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
• Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma
• The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.
• Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution
• Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension
• Comparison of Calcium Channel Blockers and Beta Blockers on Tourniquet-induced Hypertension During Intravenous Regional Anesthesia
• Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension
• Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients
• REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension
• Correlation of LONGterm Wrist ACTigraphy Recorded Physical Performance & 6-minute Walk Distance in Patients With Pulmonary Arterial Hypertension
• Sildenafil in Heart Failure With Reactive Pulmonary Hypertension
• Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH
• Chronic Hypertension and Pregnancy (CHAP) Project
• To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
• Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients
• Pharmacogenetic Prediction of Metoprolol Effectiveness
• Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH)
• A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH
• Long Term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension
• Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension
• A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension
• Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension
• Testosterone Regulation of the Natriuretic Peptide System
• Stopping Antihypertensive Treatment amOng Hypertensive Patients in Primary Care (STOP-Trial)
• 3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF
• Hypoxia and Inflammatory Injury in Human Renovascular Hypertension
• Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)
• Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
• Telmisartan in Mild to Moderate Hypertensive Patients
• Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake Population
• Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients
• The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
• CKD-828 (80/5mg) Pharmacokinetic Study
• Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension
• SYL040012, Treatment for Open Angle Glaucoma
• Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension
• Antihypertensive Medications and the Risk of Sepsis
• Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide
• Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension
• Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
• Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension
• Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension
• Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)
• TELSYS - TELmisartan Effectiveness in Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 or Older
• Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure
• Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients
• Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension
• Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus
• Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension
• A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)
• Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension
• Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension
• Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With Hypertension
• Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension
• Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood Pressure
• Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring
• Effect of Caldine® on Renal Function in Balanced Hypertension
• Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension
• Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy
• Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension
• Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals
• Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension?
• Tissue Sodium in Pre-hypertensive Patients
• An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
• Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients
• Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension
• A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients
• Selonsertib in Adults With Pulmonary Arterial Hypertension
• Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation
• The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy
• A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
• Safety of Terbogrel in Patients With Primary Pulmonary Hypertension
• Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension
• A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide
• A Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular Dysfunction
• Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension
• Pulmonary Arterial Denervation in Patients With Pulmonary Hypertension Associated With the Left Heart Failure
• Treatment of Hypertension in Tibetan Adult Population
• Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusion
• Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension
• Treatment of HYpertension: Morning Versus Evening
• Effect of Oral Caffeine and L-Citrulline Supplementation on Arterial Function in Healthy Males
• Study 3: Minocycline Decreases Microglia Activation
• Dexmedetomidine for Postoperative Analgesia After Bariatric Surgery
• Phase I Study of Nicotinamide for Early Onset Preeclampsia
• Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」
• Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension
• Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension
• Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential Hypertension
• A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension
• to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and Rosuvastatin
• To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets
• Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With Hypertension
• Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension
• A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)
• A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)
• Pharmacovigilance and Patient Compliance in Hypertensive Patients
• Micardis®. Observational Study in Patients With Essential Hypertension
• A Study of LY2623091 in Participants With High Blood Pressure
• Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION)
• Micardis® in Patients With Essential Hypertension
• Pharmacokinetics of BIBR 277 in Hypertensive Patients
• BIBR 277 Capsules in Hypertensive Patients With Nephropathy
• Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)
• Diuretic Comparison Project
• Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension
• Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension
• 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
• Azilsartan/Amlodipine Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey"
• Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
• Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
• Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy
• Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension
• Telmisartan Compared With Enalapril in Elderly Patients With Blood Hypertension
• BIBR 277 Capsule in Patients With Essential Hypertension
• Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension
• Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension
• Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension
• MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring
• Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension
• Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension
• Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension
• Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)
• Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive Patients
• Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy
• Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide
• Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension
• Oral Nifedipine Versus Oral Labetalol
• Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
• Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID)
• A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia
• Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"
• Diuretics for Postpartum High Blood Pressure in Preeclampsia
• The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension
• Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)
• Fimasartan/Amlodipine Combination Phase III
• Safety, Tolerability, Pharmacokinetic, Including Food Interaction, and Pharmacodynamic Profile of BIA 5-1058.
• Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep
• Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension
• Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension
• Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients
• An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
• Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance
• 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
• Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health
• Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
• Simvastatin Effect on Portal Hypertension
• Study 2: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients
• Study 1: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients
• Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction
• Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure
• A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• OPsumit USers Registry
• Amiloride for Resistant Hypertension
• Ambulatory vs Office BP Management Usual Care for Diagnosing and Managing Hypertension: A Pilot Study
• Carvedilol PAH A Pilot Study of Efficacy and Safety
• Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH )
• Endothelin Receptor Function and Acute Stress
• Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH
• Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension
• Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
• Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
• A Study to Evaluate Pharmacokinetics of Tafluprost Ophthalmic Solution (0.0015%) in Pediatric Patients With Glaucoma or Ocular Hypertension
• Trimetazidine in Pulmonary Artery Hypertension
• Neural Mechanism of Aldosterone-induced Insulin Resistance
• Chlorthalidone and HCTZ Impacts on Platelet Activation
• Azilsaltan Tablets (Azilva Tablets) Special Drug Use Surveillance "Hypertension Complicated by Diabetes "
• Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
• Microvascular Function in Primary Aldosteronism
• A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323
• EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension
• Azilsartan Tablets Special Drug Use Surveillance: Long-term Use
• Systolic Hypertension in Europe Placebo-Controlled Trial
• Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics.
• Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients
• A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)
• A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT™ in France, Italy and Spain
• A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R
• A Multiple Dose Titration Study of MK-8892 in Participants With Pulmonary Hypertension and Left Heart Disease (MK-8892-007)
• Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions
• The Hypotensive Effect of Metformin in Hypertensive Patients.
• Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.
• Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
• Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"
• Carvedilol vs Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding
• Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation
• CKD-330 Drug-Drug Interaction Study (Candesartan)
• CKD-330 Drug-Drug Interaction Study (Amlodipine)
• Emerging Biomarkers in Hypertension
• Study of Efficacy and Safety of CVAA489 in Hypertensive Patients
• A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
• Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
• Effects of Oral Sildenafil on Mortality in Adults With PAH
• A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension
• Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
• Dexmedetomidine Premedication in Hypertensive Patients
• PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension
• Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure
• Comparative Study of the Effects of Telmisartan and Nebivolol
• Conditioned Pharmacotherapeutic Effects in Hypertension
• Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure
• Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.
• To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension
• Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension
• Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil
• Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus
• Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan
• Sympathetic Renal Denervation Versus Increment of Pharmacological Treatment in Resistant Arterial Hypertension.
• Center of Research Translation (CORT) Project 2
• Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT
• Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)
• Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension
• The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone
• Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension
• Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion
• Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
• A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
• Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.
• Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose
• Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)
• A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma
• Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial
• Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor
• Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions
• Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions
• A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension
• Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure
• A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting
• PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study
• The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
• Non-invasive Haemodynamic Assessment in Hypertension
• Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
• Renal Sympathetic Denervation Prevents Atrial Fibrillation in Patients With Hypertensive Heart Disease: a Pilot Study
• Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension
• SER100 in Isolated Systolic Hypertension
• Efficacy and Safety of TELMINUVO to Stage 2 Hypertension
• Vascular Dysfunction in Human Obesity Hypertension
• Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension
• An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More
• Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension
• Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study
• Add-on to Micamlo BP Trial
• Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension
• A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Hypertension
• Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)
• Comparision of Blood Pressure Variability Between Amlodipine and Losartan
• Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function
• Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of Heart
• Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure: Extent of Renal Damage
• Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery
• Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine
• 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension
• Hydroxyurea in Pulmonary Arterial Hypertension
• Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease
• A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension
• Safety Study of Nebivolol for COPD Patients
• Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
• The Effects of Social Support and Oxytocin Administration on Physiological Stress Reactivity in Essential Hypertension
• A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
• Acute Dosing of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-003)
• A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
• Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control
• Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients
• Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-005)
• Aliskiren Study of Safety and Efficacy in Senior Hypertensives
• To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin
• Nebivolol, Lifestyle Modification and Arterial Stiffness
• Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease
• Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia
• Effects of REnal Denervation for Resistant Hypertension on Exercise Diastolic Function and Regression of Atherosclerosis and the Evaluation of NEW Methods Predicting A successfuL Renal Sympathetic Denervation (RENEWAL-EXERCISE, -REGRESS, and -PREDIC
• A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
• 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension
• Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension
• Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia
• Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
• Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy
• Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine
• The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy
• Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
• Beraprost-314d Added-on to Tyvaso® (BEAT)
• Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study
• Renal Denervation in Patients After Acute Coronary Syndrome
• Rosuvastatin for Preventing Complications in Renal Ablation
• Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil
• Etiology of Sleep Apnea-related Hyperaldosteronism - BP Treatment
• Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients
• Effect of Antihypertensive Agents Over Sleep Apnea
• Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
• Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease
• Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT
• Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation
• A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
• ACE Inhibitors Combined With Exercise for Seniors - Pilot Study
• Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure
• VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension
• Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension.
• An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
• (-)-Epicatechin and Pulmonary Arterial Hypertension
• A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension
• Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan
• Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With St
• Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency Patients
• CSPPT- Chronic Kidney Diseases Study
• The Effects of Dexmedetomidine to Postoperative Awakening and Extubation-related Changes in Blood Pressure
• A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension
• Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
• Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension
• To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers
• A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension
• Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
• Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension
• A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons
• Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension
• Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine
• Iron Status and Hypoxic Pulmonary Vascular Responses
• Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument
• Resveratrol and Cardiovascular Health in the Elderly
• Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
• MSC for Occlusive Disease of the Kidney
• Targeting the Right Ventricle in Pulmonary Hypertension
• Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy
• Bedtime Administration of Amlodipine Versus Lisinopril
• HIGH Altitude CArdiovascular REsearch in the ANDES
• A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
• The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.
• Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE
• Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function
• A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
• Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function
• A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study
• Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome
• Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH)
• Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone
• Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg
• Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes
• Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.
• A Rising Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics of MK-8892 (MK-8892-001)
• Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions
• Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)
• Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression
• A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
• Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension
• Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension
• Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
• Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients
• Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention
• Effect of Azilsartan on Aldosterone in Postmenopausal Females
• The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)
• Clinical Study for Patients With Hypertension Associated With Dyslipidemia
• Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt Loading
• Azilsartan Circadian and Sleep Pressure
• Effects of Bisoprolol and Atenolol on Sympathetic Nervous Activity and Central Aortic Pressure in Patients With Essential Hypertension
• Clonidine Versus Captopril for Treatment of Postpartum Very High Blood Pressure
• Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1
• Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment
• A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension
• Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns
• Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension
• Blood Pressure Outcomes With Liraglutide Therapy
• A Pilot Study of Chlorthalidone Among Patients With Poorly Controlled Hypertension and CKD
• Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT)
• EBMtrialcentral- Comparing Initial Diuretic Therapies Using a Collaborative Network
• Tadalafil Effects in Left Ventricle Diastolic Dysfunction in Resistant Hypertensive Patients
• Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome
• HaemoDYNAMICs in Primary and Secondary Hypertension
• Effectiveness of Night Administration of Low Dose Aspirin in Hypertensive Patients
• Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome
• Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
• Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
• Renal Sympathetic Denervation in Patients With Chronic Kidney Disease and Resistant Hypertension
• Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients
• An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments
• Renal Response to Lower Body Negative Pressure in Pre-hypertensive States
• Ambrisentan for Treatment of Portopulmonary Hypertension
• Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
• Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH
• Inhaled Milrinone in Cardiac Surgery
• Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05
• A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
• Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children
• Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH
• Bosentan and Pulmonary Endothelial Function
• A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn
• The Effect of Sorafenib on Portal Pressure
• Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM
• Renal Sympathetic Denervation in Patients With Drug-resistant Hypertension and Symptomatic Atrial Fibrillation
• Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients
• Spironolactone for Pulmonary Arterial Hypertension
• Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions
• Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions
• Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted Conditions
• Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions
• Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity
• BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Evaluation of Lysine-Specific Demethylase 1
• Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia
• A Randomized Trial of Udenafil Therapy in Patients With Mild Pulmonary Hypertension [ULTIMATE-Mild PHT]
• Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
• Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension
• A Trial of Fimasartan for Early Diastolic Heart Failure
• Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension
• Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation
• Exercise Capacity and Quality of Life in Patients With PPH Receiving Short Term Oral L-Citrulline Malate
• Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension
• To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure
• Oral Nitrite in Adults With Metabolic Syndrome and Hypertension
• Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension
• The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension
• A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension
• Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma
• Pharmacokinetics of Sildenafil in Premature Infants
• Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control
• ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects
• An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®
• Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine
• Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients
• A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension
• A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002)
• 24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension
• A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT
• Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension)
• Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People
• Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost
• Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers
• FK506 (Tacrolimus) in Pulmonary Arterial Hypertension
• Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive Patients
• A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
• Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
• Resistant Hypertension Optimal Treatment
• Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension
• An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension
• Korean Life-Style Modification Effects on Blood Pressure
• Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension
• Study of Cardiovascular Disease and Obstructive Sleep Apnea
• A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy
• Efficacy and Safety of CKD-828 to Stage 2 Hypertension
• A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
• Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects
• Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension
• GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy
• Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
• Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy
• Effect of Brief Nebulization of Milrinone on Pulmonary Arterial Pressure Before Cardiopulmonary Bypass on Mitral Valve Surgery Patients
• Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment
• Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD
• Effect of Renal Denervation on NO-mediated Sodium Excretion and Plasma Levels of Vasoactive Hormones
• Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain
• Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension
• DMTA07 Combine With Amlodipine Treatment in Patients With Hypertension
• Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine
• Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg
• New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering
• Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?
• Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine
• Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients
• Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension
• Safety and Efficacy of Therapeutic INduced HYPERTENSION in Acute Non-cardioembolic Ischemic Stroke (SETIN-HYPERTENSION)
• Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension
• Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)
• Probiotics for Liver Cirrhosis With Portal Hypertension
• A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)
• Safety and Tolerability and Efficacy of LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction
• A Single Rising Dose Study of MK-8150 (MK-8150-001)
• The Study of Apelin-APJ System on Pulmonary Hypertension Patients and Healthy Subjects
• A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
• Remodulin® to Oral Treprostinil Transition
• IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer
• Use of Beta-blockers and Risk of New Onset Diabetes
• PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)
• An Open Label Access Study For Subjects Who Completed A1481156
• The Effects of Sodium and Potassium on Blood Pressure, Vascular Function and Renal Function
• 8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension
• Imatinib and Carvedilol for High Blood Pressure in the Lungs in Adults With Sickle Cell Disease
• Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
• The Safety Evaluation of Drug Combinations Against High Altitude Pulmonary Hypertension
• Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older Adults
• Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives
• An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
• Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy
• Sildenofil in Persistent Pulmonary Hypertension in Newborns
• Inhaled Treprostinil for PAH: Open-label Extension
• Safety and Efficacy of Inhaled Treprostinil in Patients With PAH
• Perindopril Amlodipine for the Treatment of Hypertension
• Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)
• Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia
• A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers
• Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension
• Anastrozole in Patients With Pulmonary Arterial Hypertension
• Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia
• Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.
• Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy
• Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301
• The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers
• Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Setting
• Study of AR-13324 in Patients With Elevated Intraocular Pressure
• Effect of Midazolam on White-coat Hypertensive Dental Patients
• Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
• Effectiveness of Viscum Album Mother Tincture as an Anti-hypertensive in Essential Hypertension
• The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured Patients
• A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension
• Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension
• A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial Function
• Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for Hypertension
• Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension
• Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With Hypertension
• Preeclampsia: A Marker for Future Cardiovascular Risk in Women
• A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension
• Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension
• Revatio Portal-Pulmonary Arterial Hypertension Trial
• Nesiritide in Resistant Hypertension
• Efficacy of Changing to TRAVATAN® From Prior Therapy
• Travacom Post Marketing Surveillance Study
• Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive Patients
• Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension
• Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents
• Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients
• Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients
• CKD-828 S-Amlodipine Non-Responder Trial
• Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria
• Effect of Febuxostat on Blood Pressure
• Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes
• A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
• Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
• Rosuvastatin Effect on Serial Echocardiographic Measurement of Coronary Flow Velocity Reserve
• Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension
• Effect of Stevioside in Postpandrial Glucose in Healthy Adults
• A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
• Sildenafil for Post-capillary Pulmonary Hypertension in Patients Undergoing Cardiac Surgery
• A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
• A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
• Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance Arteries
• Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia
• Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension
• Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
• AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure
• Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension
• Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure
• Effects of Pioglitazone in Hypertensive Patients
• Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension
• Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension
• Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study
• Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension
• Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)
• Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)
• Shiga Microalbuminuria Reduction Trial-2
• A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor
• Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
• Effects of Apelin on the Lung Circulation in Pulmonary Hypertension
• Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension
• Genetic Mechanisms in Human Hypertension
• A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone
• Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in Germany
• Fludrocortisone's Test in Salt Sensitivity
• Travoprost 3-Month Safety and Efficacy Study
• Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%
• Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia
• IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) Patients
• Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients
• A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1)
• Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)
• Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker
• Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost
• Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost
• Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia
• SPHERIC-1. Sildenafil and Pulmonary HypERtension In COPD
• The Impact of Nebivolol Versus Metoprolol on Quality of Life
• Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension
• Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
• Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain
• The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome
• Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial Hypertension
• A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Inhaled Nitrite in Subjects With Pulmonary Hypertension
• Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension
• A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%
• CKD-828 Telmisartan Non-Responder Trial
• Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy
• Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild Hypertension
• Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)
• 52-104 Week Off-therapy Second Extension to Study CSPP100A2365
• Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
• Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH)
• Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)
• Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension
• Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada
• Pharmacogenetics of Ace Inhibitor-Associated Angioedema
• Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension
• Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
• Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan
• Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects
• Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
• Control of Emergence Blood Pressure During Craniotomy for Tumor Surgery Between Labetolol and Diltiazem
• Effects and Safety of Menthol on Blood Pressure and Metabolic Parameters in Prehypertensive and Mild Hypertensive Patients
• Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)
• To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic Hypertension
• Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia
• An Open-labeled Trial of Ramipril in Patients With Migraine
• INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria
• Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients
• Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients
• Effect of Nigella Sativa Seed Extract on the Blood Pressure of Elderly With Hypertension
• Effects of Sildenafil in Resistant Hypertensives and Genetic Polymorphism
• Erythropoietin and Platelet Activation Markers
• Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life Setting
• Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)
• Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants
• HYPAZ: Hypertension Induced by Pazopanib
• Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension
• Blood Pressure Lowering Effect of Transcutaneous Electrical Nerve Stimulation
• Persistent Pulmonary Hypertension of the Newborn
• Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition
• Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years
• The Effect of Amiloride and Spironolactone in Patients With Hypertension
• A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension
• ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria
• Nitro Oxide Inhalation Continued With Sildenafil on Neonatal Persistent Pulmonary Hypertension
• LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension
• Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)
• A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)
• Vasopressin and Inhaled Prostacyclin in Pediatric Pulmonary Hypertension
• The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma
• Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes
• Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension
• Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age
• The Impact of Udenafil on Exercise Capacity in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients
• Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease
• The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension
• IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn
• Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension
• Efficacy of Ventavis Used in Real-life Setting.
• High Dose BAYA1040 CR: a Long Term Extension Study
• Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers
• Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension
• CKD-828(80/2.5mg) Pharmacokinetic Study_2nd
• Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH)
• Goal-Directed Therapy in Pregnant Women at High Risk of Developing Preeclampsia
• Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, Fed
• Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects
• DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension
• Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529
• The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension
• DE-111 Against Timolol Ophthalmic Solution 0.5%
• DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%
• CKD-828 (40/5mg) Pharmacokinetic Study
• Patient Preference Comparison of AZARGA Versus COSOPT
• An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Participants With Exercise-Induced Pulmonary Arterial Hypertension (PAH)
• FUTURE 3 Study Extension
• Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010)
• Efficacy and Safety of Ambrisentan in Children 8-18yrs
• 24-hour Efficacy of AR-12286
• Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension
• Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)
• Efficacy of Changing to DUOTRAV® From Prior Therapy
• Tadalafil for Sarcoidosis Associated Pulmonary Hypertension
• Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet
• Study of Inhaled Iloprost for the Treatment of Pulmonary Hypertension After Repair of Congenital Heart Disease
• Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease
• Aliskiren on Retinal Vasculature Treatment Study
• Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension
• Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C
• Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension
• Study of Inhaled Iloprost in Pediatric Pulmonary Hypertension (PH) After Surgery
• Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension
• MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)
• A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)
• Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations
• Safety of SonoVue on Pulmonary Hemodynamics
• A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).
• Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
• MK-0954E Study in Participants With Hypertension (MK-0954E-357)
• Treprostinil Combined With Tadalafil for Pulmonary Hypertension
• AR-12286 in Combination With Latanoprost
• Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients
• MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)
• Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Divided Dose of TRAVATAN®
• Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%
• Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%
• Effect of Intrathecal Clonidine in Hypertensive Subjects With Poorly Controlled Blood Pressure
• High Dose BAYA1040_Nifedipine: a Long Term Combination Study
• Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
• Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies
• Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Evaluation of Efficacy and Safety of Somatostatin Used as Inflow Modulator in Liver Transplantation.
• The Effect of Dexmedetomidine on Hemodynamic Response During Double Lumen Endotracheal Intubation
• Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension
• Iron Deficiency In Pulmonary Hypertension
• High Dose BAYA1040_Nifedipine: a Dose-comparative Study
• Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg)
• Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Effects of Aliskiren in Elderly Hypertensive Chronic Kidney Disease (CKD) Patients
• Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis
• Hemodynamic Effect of Simvastatin With Beta Blockers in Clinical Portal Hypertension
• An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
• Effect of Selective and Nonselective Cyclooxygenase Enzyme Inhibition on Arterial Blood Pressure and Cerebral Blood Flow With Exposure to Intermittent Hypoxia in Humans
• Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension
• Telmisartan and Amlodipine Versus Monocomponent Tablets
• Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)
• Iloprost Effects on Gas Exchange and Pulmonary Mechanics
• Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults
• Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome
• Bosentan for Severe Mitral Valve Dysfunction
• Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
• Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
• Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.
• Essential Hypertension
• Safety, Tolerability, and Pharmacokinetics of MK-8266 in Elderly Participants With High Blood Pressure (MK-8266-003)
• Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With Hypertension
• The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain
• Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril
• A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy
• A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension
• Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)
• Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease
• Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Amlodipine 10mg Drug Use Investigation
• Drug Interaction Between Ritonavir And Sitaxsentan
• Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan
• A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension
• Effects of Nebivolol Versus Metoprolol Succinate on Endothelial Function
• Does Administration of Etomidate and Propofol of the Anesthetic Induction of Elderly Hypertensive Patient Provide Superior Blood Pressure Stability in Response to Direct Laryngoscopy When Compared to Propofol or Etomidate Alone?
• Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease
• CKD-828(80/2.5mg) Pharmacokinetic Study
• Beta-blockers in i-PAH
• A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses
• Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008)
• Comparison of Effect of cARvedilol Compared To bISoprolol on cenTral Pulse Pressure in Hypertension (ARTIST) Study
• A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy
• A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy
• Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
• DAYLIGHT: Vitamin D Therapy in Individuals at High Risk of Hypertension
• Combined Antihypertensive Therapy and Sexual Dysfunction
• Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension
• Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension
• Clinical Pharmacology of Aliskiren in Combination With Cyclosporine in Cardiac Transplantation
• Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors
• Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound
• Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria
• A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
• Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
• Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions
• Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial
• Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular Hypertension
• Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
• Telmisartan 80mg Non-responder Trial
• Xirtam H Combination In the Treatment of Hypertension Evaluation Study.
• Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension
• Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
• Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension
• Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed Conditions
• Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions
• Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma
• Osmotic Therapy for Treatment of Intracranial Hypertension for Traumatic Brain Injury
• Esmolol or Nitroglycerin Infusion for Blood Pressure Control Prior to Cardiopulmonary Bypass (CPB) in Cardiac Surgery
• Effects of Propofol and Isoflurane on Pulmonary Vascular Resistance
• Antihypertensive Efficacy of Fixed Combination Drug
• Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients
• An Advanced Echocardiographic Evaluation of Nebivolol
• A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients
• Telmisartan+Amlodipine Fixed Dose Combination in Hypertension
• Pharmacogenomic Evaluation of Antihypertensive Responses 2
• Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension
• Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients
• Recurrent Stroke Prevention Clinical Outcome Study
• Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension
• Do Phosphodiesterase 5A Inhibitors Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension?
• The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
• Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension
• Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension
• Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension
• A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Filipino Hypertensive Subjects With Diabetes
• Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients
• Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
• Physiological Effects of Grape Seed Extract in Diastolic Heart Failure
• Intensive Vasodilator Therapy in Patients With Essential Hypertension
• Telmisartan, Amlodipine and Flow Mediated Dilation
• Safety Study of Latanoprost Slow Release Insert
• Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)
• Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters.
• A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
• Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling
• Ranolazine and Pulmonary Hypertension
• Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments
• Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events
• A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction
• A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy Volunteers
• Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency
• Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®
• A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
• Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients
• Effect of Vitamin D Replacement During Winter Months in Patients With Hypertension
• Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities
• Nitric Oxide, GeNO Nitrosyl Delivery System
• Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP)
• Hyperuricemia on Hypertension and Metabolic Syndrome
• Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
• Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients
• Phosphodiesterase-5 (PDE5) Inhibition and Pulmonary Hypertension in Diastolic Heart Failure
• Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine
• An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
• Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age
• Treatment of Adiposity Related hypErTension (TARGET)
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker
• Felodipine Event Reduction Study
• The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension
• TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch
• The Confirmatory Olmesartan Plaque Regression Study
• The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil
• Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension
• The Effects of Antihypertensive Agents on Central Blood Pressure in Healthy Participants and Participants With Hypertension (MK-0000-166) (COMPLETED)
• CKD-828 Primary Hypertension Trial(Dose-selection)
• Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension
• Effects of Atorvastatin on Blood Pressure and Urinary Albumin Excretion
• Bevacizumab and Endothelium Dependent Vasodilation
• A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
• Pathophysiology of Cardiometabolic Risk Factors in African Americans
• Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension
• Post Kidney Transplant Nocturnal Hypertension Prevalence and Management Study
• The Role of Endothelin in the Supine Hypertension of Autonomic Failure
• Treatment of Hypertension With Adalat® in Combination With Other Drugs
• Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)
• Inhaled Iloprost for Disproportionate Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD)
• Melatonin and Nighttime Blood Pressure in African Americans--24 mg Study
• Melatonin and Nighttime Blood Pressure in African Americans-8 mg Study
• Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine
• ACT-293987 in Pulmonary Arterial Hypertension
• Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension
• Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Bisoprolol in Hypertension: Effect on Concomitant Elevated Heart Rate
• Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients
• Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
• Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
• Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401
• Epoprostenol for Injection in Pulmonary Arterial Hypertension
• A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension
• A Study of Single Dose MK-3614 (MK-3614-001)(COMPLETED)
• An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy
• Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions
• Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions
• Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure
• Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3)
• Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy
• Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8266 in Hypertensive Men (MK-8266-002)
• Tezosentan in Patients With Pulmonary Arterial Hypertension
• Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension
• Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide
• Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers
• Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary Hypertension
• Renal and Hormonal Effects of Pioglitazone
• Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study
• Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn
• Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops
• Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
• Efficacy Comparison of Xalatan and Azopt on POAG and OH
• Correlation Study of Vascular Parameters in Hypertensive Men With Erectile Dysfunction
• Dichloroacetate (DCA) for the Treatment of Pulmonary Arterial Hypertension
• Resistant Arterial Hypertension Cohort Study
• Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension
• An Observational Study to Evaluate the Efficacy of Lodoz in a Population of Hypertensive Patients
• An Active-controlled, Clinical Trial to Assess Central Hemodynamic Effects of Bisoprolol in Hypertensive Patients (Central Hemodynamic Assessment Measured in Patient With HypertensION [CHAMPION])
• A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy Adults
• Tezosentan in Pulmonary Arterial Hypertension
• Blood Pressure Effects of Nebivolol Versus Lisinopril in New Onset or Worsening Hypertension Induced by Bevacizumab
• Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients
• An Observational Study to Examine the Patients With Isolated Systolic Hypertonia (ISH) Under Therapy With Eneas® (NIS ENEAS ISH)
• Sedation With Dexmedetomidine During Cardiac Catheterization
• The Influence of Furosemide on Fluid Balance and Intra-abdominal Pressure in Critically Ill Patients
• Survey to Assess Why People Are Not Responding to Treatment in Hypertension
• FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)
• To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone
• Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension
• Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)
• Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension
• Post Marketing Observational Study in Patients With Pulmonary Arterial Hypertension
• Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure Control
• A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
• Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics
• Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide
• The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension
• Hypertension Study of Ventavis® Inhalation Therapy in the Treatment of Patients With Pulmonary Arterial Hypertension (VENIS)
• Simvastatin and Diastolic Dysfunction
• Evaluation of Aliskiren Efficacy by Different Methods of Blood Pressure Measurements
• Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
• Nebivolol in Patients With Systolic Stage 2 Hypertension
• A Clinical Study With Aliskiren Alone or in Combination Therapy With Diuretic Hctz in Venezuelan Hypertensive Patients.
• Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function
• Study of Sildenafil Effects in Combination With Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Associated Pulmonary Hypertension
• Effect of BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost Inhalation in Pulmonary Arterial Hypertension
• Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan
• Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use
• The Effect of Nebivolol on Endothelial Dysfunction in African Americans With Hypertension
• Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension
• Effects of Aliskiren/Amlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive Patients
• Targeting Microvascular Dysfunction in Young Hypertensive Patients
• Hypertension Monitoring in Glioma Patients Treated With Bevacizumab
• Nebivolol in the Supine Hypertension of Autonomic Failure
• The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy
• Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients
• A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
• Cozaar XQ Re-examination Study (MK-0954-349)
• Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells
• Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria
• A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG
• Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease
• A Multiple Dose Study of MK-3614 (MK-3614-002)
• Cardiovascular-Protective Effects of Herbal Medicine Danshen-Gegen
• Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
• A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED)
• Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.
• The Effect of Probiotics (VSL) on Portal Hypertension
• Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension
• Amlodipine Prevents Morning Blood Pressure Surge Study
• A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
• Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)
• An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension
• Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED)
• Safety and Tolerability of MK-5478 in Participants With Hypertension (5478-001)
• A Single Dose Study of MK-8266 (MK-8266-001)
• Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy
• The Pharmacokinetics of Nifedipine Controlled Release Tablets in Hypertensive Patients on Hemodialysis
• Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension
• Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients
• Genetic Mechanisms in Human Hypertension Renin-angiotensin-aldosterone System (RAAS) Inhibition Study
• Reduction of Night-time Blood Pressure in Pediatric Renal Transplant Recipients
• A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure
• Idiopathic Intracranial Hypertension Treatment Trial
• Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics
• Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension
• Comparison of Endoscopic Variceal Ligation (EVL) With Propranolol in Non Cirrhotic Portal Hypertension (NCPH)
• Study to Determine the Effects of Nebivolol and Hydrochlorothiazide in African Americans With Hypertension
• Nebivolol Versus Metoprolol: Comparative Effects on Fatigue and Quality of Life
• Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension
• A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Prescribed Thelin
• Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function
• Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension
• Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics
• Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension
• Nebivolol Versus Metoprolol: Sodium Sensitivity
• Tolerance and Effect on Intraocular Pressure After Administration of SYL040012
• Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
• Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
• Effects of Intralipid Versus Olive Oil Infusions on Endothelial Function, Immune Function, Inflammatory Markers
• Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis
• Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension
• Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
• Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's
• A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM
• Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension
• Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage
• Vitamin D Deficiency in Patients With Hypertension
• L-arginine Effects on Chronic Hypertension in Pregnancy
• A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients
• Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension
• Hypertension Prevention in Pre-Hypertensive Individuals
• A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG
• The Effects of Blood Pressure Reduction on Cerebral Perfusion and Cognition in the Elderly Population
• Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension
• Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil
• Effect of Food on the Pharmacokinetics of Oral Treprostinil
• Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination
• Study of the Effects of Iron on Lung Blood Pressure at High Altitude
• Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions
• Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy
• Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy
• Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)
• B-type Natriuretic Peptide (BNP) in Human Hypertension
• Study of the Effects of Iron Levels on the Lungs at High Altitude
• A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients
• Efficacy and Tolerability of Xalatan in Patients
• Irbesartan and Amlodipine Combination in Controlling Blood Pressure
• Olmesartan Comparison to Losartan in Hypertensive Subjects
• Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension
• Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise
• To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg
• To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions
• To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions
• To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks
• Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension
• The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)
• Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension
• Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
• Effects of Nebivolol on Subclinical Left Ventricular dySfunction: A Comparative Study Against Metoprolol
• Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension
• Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure
• Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination
• Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension
• Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension
• Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients
• Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)
• Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy
• Effect of Light Meal on Pharmacokinetic and Pharmacodynamics of Aliskiren in Patients With Mild to Moderate Hypertension
• Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment
• Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension
• A Non Interventional Study To Asses The Safety, Effectiveness And Tolerability Of Quinapril (Acupil®) In An Indian Population
• Bevacizumab and Vasoconstriction
• Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Iloprost in High Risk Cardiac Surgical Patients
• Therapy of Essential Hypertension With Kinzal®/ Kinzalplus®
• Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
• Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension
• Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients
• Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension
• Inhaled Nitric Oxide (INO) In Hypoxic Respiratory Failure
• Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients
• A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension
• The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension
• Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation
• To Demonstrate the Relative Bioavailability of Atenolol Tablets
• BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension
• Early Therapy of Pulmonary Arterial Hypertension
• An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension
• Ventavis® Registry Protocol
• Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension
• Valsartan Intensified Primary Care Reduction of Blood Pressure Study
• Imatinib (QTI571) in Pulmonary Arterial Hypertension
• TC-5214 as Augmentation Therapy in Patients With Refractory Hypertension
• Salt Loading and Thiazide Intervention Study
• Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health
• Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome
• Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension
• Colloids in Severe Trauma
• Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
• Telmisartan Tab Hypertension
• MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension
• Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension
• A Study to Investigate the Antihypertensive Efficacy of MK0954
• A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma
• A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)
• To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablet Under Fasting and Fed
• To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablets Under Fasting Conditions
• Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)
• A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)
• Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients
• ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
• Smoking Study With Behavioral Therapy for Hypertensive Patients
• Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study
• Equivalence Study of Dorzolamide 2% Eye Drops Solution
• Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus
• Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension
• The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans
• Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension
• Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension
• Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed)
• Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
• Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension
• Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil
• Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions
• Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease
• Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions
• Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal
• Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab
• A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
• BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
• Safety and Efficacy Study of DuoTrav APS Versus DuoTrav
• Sildenafil for Secondary Pulmonary Hypertension Due to Valvular Disease
• Efficacy and Safety of Metoprolol Succinate Prolonged-Release Tablet in Patients With Mild to Moderate Hypertension
• Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension
• Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension
• The Effect of Amiloride and Spironolactone in Healthy Persons
• Olmesartan Medoxomil Versus Losartan in Patients With Hypertension
• The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)
• A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients
• Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension
• A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma
• A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.
• Olmesartan on Ambulatory Blood Pressure Change
• Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension
• A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension
• Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension
• Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic Rate
• Efficacy Study of Travoprost APS Versus TRAVATAN
• Evaluation of Soluble Epoxide Hydrolase (s-EH) Inhibitor in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance
• Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population
• Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension
• Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US
• Trial Comparing Metabolic Effects of Telmisartan and Amlodipine on Hypertensive Patients With Obesity and Diabetes
• Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension
• Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension
• Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma
• Bioequivalence Study in Healthy Subjects
• China Medical University Hospital (CMUH) Triapin Listing
• Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension
• Induced Hypertension for Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage:a Feasibility Study
• Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan
• Renin Profiling in Selection of Initial Antihypertensive Drug
• A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age
• Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)
• Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries
• Mechanisms and Treatment of Intradialytic Hypertension
• An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension
• Insulin Resistance in Pulmonary Arterial Hypertension
• A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives
• A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs
• Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome
• A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)
• Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension
• A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma
• Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise
• A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components
• Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension
• A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension
• A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With Hypertension
• The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG)
• Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers
• An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects
• Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular Failure
• Assessment of the Effectiveness of OLMETEC® and OLMETEC PLUS® for Treatment of Hypertension in Stage I and II Patients (Study P05254)(COMPLETED)
• A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension
• A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)
• 8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension
• Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma
• Does Sildenafil Increase Exercise Performance in Air Pollution?
• Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)
• Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)
• Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative
• Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial Dysfunction
• Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.
• The Effects of Potassium on Physiological and Cardiovascular Variables in Healthy Persons
• Sildenafil IV Bolus Study
• A Study of Glaucoma or Ocular Hypertension in Patients Within the United States
• Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®
• Clevidipine Bolus Administration in the Treatment of Hypertensive Patients Undergoing Cardiac Surgery (SPRINT)
• Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN
• Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension
• Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension
• Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil
• Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety
• Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide
• Morning Hypertension and Preminent Therapy Study
• Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)
• Comparison of 2 Doses of Mannitol on Post Traumatic Intracranial Hypertension and Cerebral Monitoring
• Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension
• China Stroke Primary Prevention Trial
• An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients
• A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure
• Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study)
• A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED)
• A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension
• Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus
• Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE
• A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy
• A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients
• Study Evaluating the Addition of Sildenafil to Bosentan Therapy in Pulmonary Arterial Hypertension
• A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential Hypertension
• Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone
• Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren Alone
• Study of Ambrisentan in Participants With Pulmonary Hypertension
• Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.
• Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension
• Vascular Improvement With Olmesartan Medoxomil Study
• A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients
• Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.
• Nifedipine (Adalat CR, BAY A1040) High Dose PK/PD Study
• Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT
• 1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT
• Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension
• Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension
• Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension
• Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension
• Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health
• FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
• Safety and Efficacy of Travoprost/Timolol BAC-free
• Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population
• Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension
• Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension
• The Role of Endothelin in Pulmonary Hypertension
• Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
• A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension
• Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)
• Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma
• Isolated Systolic Hypertension in the Elderly and Very Elderly
• Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly
• A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension
• A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia
• A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom
• Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.
• Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
• IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids
• Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients
• Role of AT1-receptor Blockers in Insulin-induced Vasodilation.
• The Assessment of Right Ventricular Contractility in Response to Sildenafil
• Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects
• Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment
• The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution
• Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension
• Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension
• SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335)
• Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans
• Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes
• Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
• Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects
• Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients
• Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?
• Coreg CR, Blood Vessel Stiffness and Blood Vessel Function
• Sildenafil for Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension
• Iloprost Power Disc-15 in Pulmonary Arterial Hypertension
• Aliskiren and Muscle Sympathetic Nerve Activity
• The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension
• Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients
• Iloprost Power 15 in Pulmonary Arterial Hypertension
• Spironolactone Versus Amiloride as an Add on Agent in Resistant Hypertension
• Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
• Effects of Travatan Z and Xalatan on Ocular Surface Health
• ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination
• Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
• Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study
• Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.
• Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension
• Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension
• Antihypertensive Effect of Simvastatin in Hypertensive Patients
• Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
• Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions
• Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions
• Losartan in Hypertensive Men and Women With Sleep Apnea Before and on Continuous Positive Airway Pressure (CPAP) Treatment
• Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day
• Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension
• Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
• The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation
• An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.
• A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension
• Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension
• One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension
• Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)
• Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension
• Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)
• Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients
• Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg
• Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage
• Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension
• Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension
• Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure
• Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TID
• Glaucoma Adherence Study, Spain
• Effects of Bosentan on Respiratory Mechanics
• An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
• Glaucoma Adherence Study
• Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs
• Hypertension in Breast Cancer Patients Receiving Bevacizumab
• The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
• The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease
• A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With Hypertension
• Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial
• Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients
• Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis
• Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure
• Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia
• Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and Hypertension
• Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension
• A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension
• Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome
• The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy
• Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)
• To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension
• A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure
• Black Education and Treatment of Hypertension (BEAT HTN)
• Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
• J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation
• Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular
• Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension
• Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril
• The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.
• To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension
• Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension.
• 18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics
• Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension
• Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients
• A Study to Evaluate the Efficacy and Safety of Quinapril or Quinapril Plus Hydrochlorothiazide in Patients With Mild to Moderate Hypertension
• Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension
• A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension
• A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients
• A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma
• Effects of Doxazosin Gastrointestinal Therapeutic System on Ambulatory Blood Pressure and Cardiovascular Risk Factors in Uncontrolled Hypertensive Patients
• A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension
• Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension
• Rapid Switch From Flolan to Remodulin in the Outpatient Clinic
• Factorial Study of Metoprolol Succinate TOPROL-XL (324A)
• Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension.
• Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost
• Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study
• A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension
• A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension
• Interaction Between Antihypertensives and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients
• Combined Renin Inhibition/Beta-blockade
• Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine
• Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing
• Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan
• Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
• The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure
• Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure
• 26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension
• Comparison of Effectiveness of Pentobarbital and Thiopental in Patients With Refractory Intracranial Hypertension
• Sodium Nitroprusside for Blood Pressure Reduction in the ICU (SNP2)
• Candesartan Effect in Second Stage Arterial Hypertension
• Adjunctive Study of AL-37807 Ophthalmic Suspension
• Atacand (Candesartan) Real Life Study
• An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination
• Antihypertensive Response to Losartan and Genetic Polymorphisms
• Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)
• Atorvastatin in Pulmonary Hypertension
• Open Label Study Telmisartan and Amlodipine in Hypertension
• Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension
• The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)
• Sildenafil and Exercise Capacity in Hypertension
• Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure
• A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.
• Pulmonary Artery Remodelling With Bosentan
• Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension
• Pharmacogenomics in Pulmonary Arterial Hypertension
• Effect of Gene Variants on Dopamine Receptor Natriuretic Responses
• Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension
• Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension
• Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension
• Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension
• FFA-Induced Hypertension and Endothelial Dysfunction
• Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients
• Vitamin D for Chemoprevention
• Safety Study of Gleevec® in Children With Pulmonary Hypertension
• African American Study of Kidney Disease and Hypertension ABPM Pilot Study
• Hypertension in Hemodialysis Patients (Aim 3)
• Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension
• Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults
• Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors
• A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)
• Patient Preference Study
• Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients
• ARIA (Atacand Renoprotection In NephropAthy Pt.)
• Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.
• Effects of Oral L-Arginine on Chronic Hypertension in Pregnancy
• N-Acetylcysteine and Arginine Administration in Diabetic Patients
• Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice
• The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension
• Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension
• Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension
• Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria
• PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites
• Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD)
• Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria
• Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels
• Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension
• Filtered Trial for Amlodipine Non-responder
• Study to Examine the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination of COREG CR and Lisinopril.
• Study to Demonstrate the Bioequivalence of the Fixed Dose Combination of COREG CR™ and Lisinopril to Its Components
• A Study to Evaluate GSK1325760A - a Long-Term Extension Study
• Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
• Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?
• Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension
• A Study Investigating the Bioequivalence of the Fixed Dose Combination of COREG CR to COREG CR and ZESTRIL.
• Filtered Trial for Telmisartan 40mg Non-responder
• Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
• Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.
• Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs
• Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
• Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for Hypertension
• BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333)
• A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)
• Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED)
• A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006)
• Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome
• Health Assessment Study (0954-946)
• Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension
• Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension
• A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
• A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
• Simvatstatin Used to Treat Pulmonary Hypertension
• A Study to Compare COREG CR to COREG CR Fixed-dose Combination in Patients With High Blood Pressure
• Effect of Lacidipine and Losartan on 24 Hour Systolic Blood Pressure Variability in Elderly Hypertensive Patients
• A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin
• Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension
• Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
• A Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study of Cardene® I.V. in Pediatric Subjects With Hypertension
• A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
• Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension
• IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Addition of Spironolactone in Patients With Resistant Arterial Hypertension
• Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension
• The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction
• A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension
• Losartan Therapy in Pulmonary Hypertension
• Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet
• Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression
• Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis
• Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan
• Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension
• Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
• Adherence Assessment With Travalert Dosing Aid
• Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives
• Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in Argentina
• Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension
• Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension
• Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
• Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension
• Does Statin Therapy Reduce Sympathoexcitation in Hypertension?
• LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)
• Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension
• Danish Carvedilol Study in Portal Hypertension
• Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
• Kanagawa Combination Anti-hypertensive Therapy (K-CAT)
• Sildenafil Effects on Pulmonary Haemodynamics and Gas Exchange in Chronic Obstructive Pulmonary Disease (COPD)
• Sympathetic Nervous System Modulation in Hypertension
• Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months
• Hemodynamic Response After Six Months of Sildenafil
• Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension
• Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
• Effect of Epigallocatechin-Gallate on Inner Retinal Function in Ocular Hypertension and Early Glaucoma
• Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension
• A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension
• Effect of Celecoxib on Markers of Vascular Inflammation
• Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension
• The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension
• Assessment of Compliance With Antihypertensive Telmisartan Therapy
• The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting
• A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
• Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension
• Efficacy and Safety of Lacidipine and Amlodipine on Blood Pressure in Korean ISH Patients Aged 60 to 80 Years
• Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study
• Vitamin D and Blood Pressure
• Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
• Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction
• A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension
• Nijmegen Antihypertensive Management Improvement Study
• Prevention of Diabetes and Hypertension
• Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)
• An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension
• Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension
• Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension
• Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
• The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism
• Secondary Prophylaxis After Variceal Bleeding in Non-Responders
• MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)
• Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension
• An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essent
• Nitrate and Hypertension in Heart Transplanted Patients
• A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)
• Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy
• Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
• Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension
• Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
• Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant
• A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension
• Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma
• Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing
• Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient
• Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension
• Effect of High and Low Sodium Diets on Blood Pressure in Hypertensive Patients Treated With Aliskiren
• Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
• Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults
• Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis
• The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension
• Effect of Ketamine (Ketalar) on Intracranial Pressure
• Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension
• 6R-BH4 Pulmonary Arterial Hypertension Study
• Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure
• Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo
• Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure
• Combination Therapy in Pulmonary Arterial Hypertension
• Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
• The Efficacy of Spironolactone in Patients With Resistant Hypertension
• To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.
• A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension
• Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
• Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.
• Double Blind Crossover Comparison of Diuretics in the Young
• Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation
• Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
• Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
• Understanding Pine Bark Extract as an Alternative Treatment (UPBEAT) Study
• Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension
• Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension
• Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension
• Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
• Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
• A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure
• Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study
• Effects of Cocoa Intake on Blood Pressure in Elderly Individuals With Mild Hypertension
• Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension
• Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension
• Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome
• A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient
• Antihypertensive Treatment in Acute Cerebral Hemorrhage
• Efficacy of Rostafuroxin in the Treatment of Essential Hypertension
• Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure
• Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension
• Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension
• Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
• An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension
• One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension
• Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.
• Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients
• Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.
• Effects of Continuous Positive Airway Pressure and Valsartan Treatments on Arterial Blood Pressure in OSAS Patients
• Treatment of Severe Hypertension During Pre-Eclampsia: A Preliminary Equivalence Study Between Urapidil and Nicardipine
• Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study
• Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.
• Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension
• Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors
• Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin.
• Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension
• An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes
• Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops
• An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure
• Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension
• Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)
• Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)
• Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients
• Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome
• Antihypertensive Effectiveness of the Associations of Hydrochlorothiazide and Amiloride and Hydrochlorothiazide and Enalapril
• A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients
• DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
• DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
• A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents
• Irbesartan and Atenolol in Hypertensive Heart Disease
• Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension
• A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
• Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Patients
• A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients
• Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin
• A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension
• Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg
• A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).
• Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension
• Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension
• Placebo Controlled Trial of Bosentan in Scleroderma Patients
• Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension
• A Study in People With Mild Hypertension
• Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin
• A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension
• Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension
• Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)
• Short Course Terlipressin for Control of Acute Variceal Bleeding
• Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria
• A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly
• Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus
• Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine
• BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
• Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension
• Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension
• A Clinical Study to Evaluate the Effects of Darusentan on Safety and Efficacy in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Blood Pressure Lowering Drugs
• I PREVENT - Irbesartan In Hypertensive Diabetic Patients
• Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension
• Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor Autoantibody
• Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide
• A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study
• Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis
• Safety and Effects of Ramipril Combined With Candesartan
• Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
• Hyzaar Asia HEAALTH (0954A-950)
• Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension
• Effects of Thiazide Diuretics on Sympathetic Nervous System in Hypertension
• DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension
• Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
• Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension
• Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
• Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension
• Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension
• Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)
• A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension
• Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension
• The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial
• Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
• Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls
• Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension
• Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.
• Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)
• The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients
• Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133)
• I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients
• Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria
• Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery?
• Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.
• Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
• Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
• Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
• 24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients
• DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
• A Comparison of Compliance Between Clonidine Patch and Methyldopa for the Treatment of Chronic Hypertension in Pregnancy
• Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
• Effect of Pioglitazone on Ambulatory Blood Pressure
• 8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension
• A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy
• Sildenafil to Treat HIV-Associated Pulmonary Hypertension
• Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension
• A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension
• The Effects of Cilnidipine on Metabolic Syndrome Improvement
• Ramipril - Hypertension
• IV Double and Triple Concentrated Nicardipine for Stroke and ICH
• Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension
• FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)
• FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
• Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension
• Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension
• Bosentan in Children With Pulmonary Arterial Hypertension
• Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
• Bosentan in Children With Pulmonary Arterial Hypertension Extension Study
• Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
• Effect of Regular Sildenafil on Blood Pressure and Arterial Function in Hypertension
• Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia
• Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary Hypertension
• A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients
• Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension
• Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH)
• A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)
• A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension
• SPP100 Dose Finding Study in Japan
• Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)
• MK0954A-264 Filter Study (0954A-264)(COMPLETED)
• Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
• Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)
• Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose
• The STRETCH Study: Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension
• The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension
• Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
• Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension
• SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction
• SPP100 (Aliskiren) Regimen in Patients With Severe Hypertension
• Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy
• Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy
• A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine
• Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial
• Obese Hypertension Study (0954-315)
• Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension
• Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
• Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients
• Uric Acid in Essential Hypertension in Children
• Allopurinol for Renal Transplant Associated Hypertension in Children
• Primary Prevention of Hypertension in Obese Adolescents
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• Japan Morning Surge-1 Study
• AVE7688 in Patients With Mild to Moderate Blood Pressure
• Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device
• APROVE : Irbesartan in Hypertension
• The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control
• Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo
• Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension
• Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
• A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
• Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED)
• PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)
• Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM
• PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
• DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril
• Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension
• COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension
• A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure.
• Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia
• Conditioned Placebo Effects and Treatment of Hypertension
• Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive Patients
• Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension
• Bosentan in Treatment of Pulmonary Arterial Hypertension
• Irbesartan in Hypertension
• AMISH : Aprovel for Management of Isolated Systolic Hypertension
• Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours
• Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension
• Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate Hypertension
• A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure
• Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by Hypoxia
• Dialysate Sodium Individualization in Hemodialysis
• Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension
• Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects
• 307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects
• A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia
• Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C
• Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years
• A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.
• Behavioural Treatment of Hypertension
• A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)
• Pharmacogenomic Evaluation of Antihypertensive Responses
• Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age
• Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age
• Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age
• Uric Acid and Hypertension in African Americans
• Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome
• A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg
• Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes
• The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure
• Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus
• A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
• Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension
• A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)
• A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients
• SMOOTH - Blood Pressure Control in Diabetic/Obese Patients
• 3-D Transcranial Ultrasound Analysis Study
• Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5
• Melatonin Supplements for Improving Sleep in Individuals With Hypertension
• Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)
• A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension
• Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery
• A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)
• Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension
• Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)
• Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)
• Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)
• Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.
• Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure
• Comparison of Diuretic-based With Non-diuretic Based Hypertension Therapy Using Echocardiographic Measures
• Induced Hypertension for Acute Ischemic Stroke
• TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial
• Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers
• Observational Study of the Prognosis in Treated Arterial Hypertension
• PHARES Study: Management of Resistant Hypertension
• Treatment of Supine Hypertension in Autonomic Failure
• Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients
• Olmesartan as an add-on to Amlodipine in Hypertension
• Amlodipine as add-on to Olmesartan in Hypertension
• The Effect of North American Ginseng on Blood Pressure in Individuals With Hypertension
• Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension
• A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients
• Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood Pressure
• A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood Pressure
• A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine
• Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension
• A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure.
• A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg
• A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients
• A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.
• A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders Patients
• A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.
• A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension
• Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension
• Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.
• Effects of Tetrahydrobiopterin on Blood Pressure
• Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes
• Natrecor for Pulmonary Hypertension in Lung Transplants
• Heart and Blood Pressure Study: The Effect of Aortic Impedance on Myocardial Relaxation
• Rationale and Design for Shiga Microalbuminuria Reduction Trial
• S90652 in Paediatric Hypertension
• S90652 in Paediatric Hypertension
• A Study of the Safety and Efficacy of Long-Term Nebivolol Use in Hypertensive Patients
• A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients
• A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients
• A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Hypertension
• A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate Hypertension
• Hypertension Control Based on Home Blood Pressure
• Treatment Targets for Chronic Hypertension in Pregnancy
• Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
• Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertension
• Treatment of Insulin Resistance in Hypertensive, Obese Adolescents
• Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension
• Olmesartan in Essential Hypertension
• Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension
• Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker
• A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin
• An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension
• The Effect of Statin Use on Vascular Function in Hypertensive Subjects
• Simvastatin as a Treatment for Pulmonary Hypertension
• The Autonomic Nervous System and Obesity
• Effect of High Blood Pressure and Antihypertensive Treatment on Brain Functioning in Children
• Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia
• Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
• A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential Hypertension
• Hypertension and Cardiovascular Risk Factors
• Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients.
• Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
• Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
• A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg
• A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.
• A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure
• Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction
• VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women
• A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
• A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
• VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis
• VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria
• Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension
• A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age
• A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension
• VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil
• Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone
• Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
• A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension
• Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone
• Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension
• A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
• To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.
• Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension
• Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension
• Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese Patients
• Efficacy and Safety of Moxonidine in Indian Patients
• Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension
• Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension
• Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes
• A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.
• Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension
• A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
• The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH
• Amlodipine Diabetic Hypertension Efficacy Response Trial
• A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma
• A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo
• MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)
• Tadalafil in Subjects With Mild to Moderate Hypertension
• Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension
• Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)
• 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension
• Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension
• Olmesartan Medoxomil in Hypertension and Renal Impairment
• Olmesartan Pediatric Pharmacokinetic (PK) Study
• Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure
• Cognitive/Cerebrovascular Consequences of HTN Treatment
• Danish Hypertension Prevention Project - DHYPP
• To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension .
• A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension
• Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)
• The Long-term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years
• A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.
• Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT
• Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women
• Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)
• Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg
• Sildenafil and Pulmonary Artery Pressure
• Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension
• Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans
• Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy
• A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes
• Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels
• Evaluation of the Long-Term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension
• Extracellular Fluid in Resistant Hypertension
• The Renin-Angiotensin System in Essential Hypertension
• Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)
• ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)
• Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.
• A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma
• Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
• Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension
• Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial
• NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn
• Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension
• L-Arginine Metabolism in Essential Hypertension
• Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension
• OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
• INVEST: INternational VErapamil SR Trandolapril STudy
• A Morbidity-Mortality and Remodeling Study With Valsartan
• A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to
• Diuretics In the Management of Essential Hypertension (DIME) Study
• Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension
• STITCH (Simplified Therapeutic Intervention To Control Hypertension)
• Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance
• IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs
• Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline
• PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension
• Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
• Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients
• COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
• Rosiglitazone Plaque Study
• The Hypertension in the Very Elderly Trial (HYVET)
• Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)
• Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis
• Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)
• A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension
• Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women
• Endothelial Cell Dysfunction in Pulmonary Hypertension
• Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
• Clevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC)
• Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP)
• Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)
• Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)
• Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)
• Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)
• Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II
• ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)
• Systolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA)
• Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)
• The Effect of Tracleer® on Male Fertility
• Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension
• Natrecor in Pulmonary Hypertension
• Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
• Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients
• Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension
• A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension
• Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension
• Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension
• Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension
• Secondary Prevention of Small Subcortical Strokes Trial
• A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension
• A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension
• A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)
• A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
• Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32
• Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98
• Study of TRAVATAN in Subjects With Iris Pigmentation Changes
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69
• Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension
• The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling
• The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)
• Treatment of Pediatric Hypertension With Altace Trial
• Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose
• Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension
• Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension
• Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients
• Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure
• Hypertension Screening and Treatment Program
• Prevention of Esophageal Varices by Beta-Adrenergic Blockers
• Inhaled Nitric Oxide Study for Respiratory Failure in Newborns
• Early Inhaled Nitric Oxide for Respiratory Failure in Newborns
• Genetic Epidemiology of Responses to Antihypertensives
• Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis
• Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension
• Prevention of Esophageal Varices by Beta-Adrenergic Blockers
• Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
• Oral Calcium in Pregnant Women With Hypertension
• Diuretics, Hypertension, and Arrhythmias Clinical Trial
• Treatment of Mild Hypertension Study (TOMHS)
• Systolic Hypertension in the Elderly Program (SHEP)
• Hypertension Prevention Trial (HPT) Feasibility Study
• Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
• Control of Hypertension by Non-Pharmacologic Means
• Hypertension Detection and Follow-up Program (HDFP)
• Treatment of Hypertension
• Ocular Hypertension Treatment Study (OHTS)